Retraction Note: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

Nature. 2020 Jun;582(7810):134. doi: 10.1038/s41586-020-2273-1.

Jing Y Krzeszinski¹, Wei Wei¹, HoangDinh Huynh¹, Zixue Jin¹, Xunde Wang¹, Tsung-Cheng Chang², Xian-Jin Xie^{3

4}, Lin He⁵, Lingegowda S Mangala^{6

7}, Gabriel Lopez-Berestein^{7

8}, Anil K Sood^{6

7

9}, Joshua T Mendell^{2

3}, Yihong Wan^{10

11}

¹ Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, 75390, Texas, USA.
² Department of Molecular Biology, The University of Texas Southwestern Medical Center, Dallas, 75390, Texas, USA.
³ Simmons Cancer Center, The University of Texas Southwestern Medical Center, Dallas, 75390, Texas, USA.
⁴ Department of Clinical Sciences, The University of Texas Southwestern Medical Center, Dallas, 75390, Texas, USA.
⁵ Division of Cellular and Developmental Biology, Molecular and Cell Biology Department, University of California at Berkeley, Berkeley, 94705, California, USA.
⁶ Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA.
⁷ Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA.
⁸ Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA.
⁹ Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA.
¹⁰ Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, 75390, Texas, USA. yihong.wan@utsouthwestern.edu.
¹¹ Simmons Cancer Center, The University of Texas Southwestern Medical Center, Dallas, 75390, Texas, USA. yihong.wan@utsouthwestern.edu.

Abstract

A Retraction to this paper has been published and can be accessed via a link at the top of the paper.